Article Versions Notes

Matsubara E, Komohara Y, Esumi S, Shinchi Y, Ishizuka S, Mito R, Pan C, Yano H, Kobayashi D, Fujiwara Y, et al. SPP1 Derived from Macrophages Is Associated with a Worse Clinical Course and Chemo-Resistance in Lung Adenocarcinoma. Cancers. 2022; 14(18):4374. https://doi.org/10.3390/cancers14184374

Matsubara, Eri, Yoshihiro Komohara, Shigeyuki Esumi, Yusuke Shinchi, Shiho Ishizuka, Remi Mito, Cheng Pan, Hiromu Yano, Daiki Kobayashi, Yukio Fujiwara, and et al. 2022. "SPP1 Derived from Macrophages Is Associated with a Worse Clinical Course and Chemo-Resistance in Lung Adenocarcinoma" Cancers 14, no. 18: 4374. https://doi.org/10.3390/cancers14184374

Matsubara, E., Komohara, Y., Esumi, S., Shinchi, Y., Ishizuka, S., Mito, R., Pan, C., Yano, H., Kobayashi, D., Fujiwara, Y., Ikeda, K., Sakagami, T., & Suzuki, M. (2022). SPP1 Derived from Macrophages Is Associated with a Worse Clinical Course and Chemo-Resistance in Lung Adenocarcinoma. Cancers, 14(18), 4374. https://doi.org/10.3390/cancers14184374